Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Shunfeng Biotechnology
Shandong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Shandong Shunfeng Biotechnology has developed proprietary CRISPR gene editing enzymes Cas-SF01 and Cas-SF02, validated in more than 70 labs and companies worldwide, and licensed globally for all crop types to partners such as KWS and Origin Agritech to accelerate development of higher-yield, higher-quality, and nutritionally improved crop varieties. The company developed China’s first approved gene-edited crop (a high-oleic-acid soybean) that obtained production and application biosafety certification, marking a regulatory and commercial milestone for gene-edited crops in China.
- Therapeutic areas
- Other
- Modalities
- Gene therapyCRISPR-based therapy
- Industry
- Non-Drug Biotech
02
Partnerships
KWS (global licensing agreement for use of Cas-SF01 and Cas-SF02 in plant breeding for all crop types)Origin Agritech (patent license agreement for Cas-SF01 gene editing tool to support corn breeding and “Smart Plant Architecture” program)Multiple (70+) laboratories and enterprises worldwide using Shunfeng’s gene editing technology
Beyond the preview
Go deeper on Shandong Shunfeng Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shandong Shunfeng Biotechnology.